Skip to main content
Screener/Healthcare/Biotechnology

ADPT — Adaptive Biotechnologies Corporation

NASDAQ
$26.63-1.54 (-5.47%)
Mid CapUnder $50HealthcareFastest GrowingHigh Beta
$12.00
$30.74
$26.17
$27.97
EPS (TTM)$-0.33
P/E Ratio-36.13
Dividend Yield—
Market Cap$4.07B
Volume2.57M
Prev Close$28.17
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$70.9M-$20.0M$-0.1373.6%-28.3%
Q4 '25$71.7M-$13.6M$-0.0974.6%-18.9%
Q3 '25$94.0M$9.5M$0.0680.7%10.2%
Q2 '25$58.9M-$25.6M$-0.1769.4%-43.5%
Q1 '25$52.4M-$29.9M$-0.2067.6%-56.9%
Q4 '24$47.5M-$33.7M$-0.2362.0%-71.0%
Q3 '24$46.4M-$32.1M$-0.2264.1%-69.1%
Q2 '24$43.2M-$46.2M$-0.3155.3%-107.0%
Get Your Daily Market Recap